Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC

Public

Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC

N

Shared by NobleBlocks on Aug 15, 2024 • 12:00 AM UTC

Authors:

Shun Lu

,

Terufumi Kato

,

Xiaorong Dong

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Aug 15, 2024 • 12:00 AM UTC

NobleID:w1/20260526/C82EF023

DOI:10.1056/nejmoa2402614

No figures available

Generate Podcast

Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC | NobleBlocks